Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure
Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure
Active, not recruiting · NCT07478575 · Registry updated 2026-03-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Urogenital Diseases, anemia, cardiovascular disorder, heart disorder, heart failure, hematologic disorder, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Not stated | 2026-03-17 | NCT07478575 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Slovenian Research Agency | 5 |
| University Medical Centre Ljubljana | 81 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Medical Centre Ljubljana | Ljubljana | Slovenia | 35 |